NCT06592144View on ClinicalTrials.gov

TESTO-TRIAL: Use of Testosterone in Critically Ill Patients

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

94

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

August 2, 2026

Study Completion Date

November 2, 2026

Conditions

Weaning FailureMuscle WeaknessMechanical Ventilation ComplicationICU Acquired WeaknessMobility Limitation

Interventions

DRUG

Testosterone cypionate (200mg/3ml)

It will be administered intramuscularly every 5 days, totaling 3 doses.

OTHER

Sesame oil (3ml)

It will be administered intramuscularly every 5 days, totaling 3 doses.

Trial Locations (1)

14150-000

Hospital Estadual Serrana, Serrana

All Listed Sponsors

lead

Leticia Maria Defendi Barboza Marson

OTHER